This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Egyházi, E Articles by Durban, E Search for Related Content PubMed PubMed Citation Articles by Egyházi, E Articles by Durban, E

Microinjection of anti-topoisomerase I immunoglobulin G into nuclei of Chironomus tentans salivary gland cells leads to blockage of transcription elongation.

Department of Medical Cell Biology, Karolinska Institutet, Stockholm, Sweden.

ABSTRACT

Purified anti-topoisomerase I immunoglobulin G (IgG) was microinjected into nuclei of Chironomus tentans salivary gland cells, and the effect on DNA transcription was investigated. Synthesis of nucleolar preribosomal 38S RNA by RNA polymerase I and of chromosomal Balbiani ring RNA by RNA polymerase II was inhibited by about 80%. The inhibitory action of anti-topoisomerase I IgG could be reversed by the addition of exogenous topoisomerase I. Anti-topoisomerase I IgG had less effect on RNA polymerase II-promoted activity of other less efficiently transcribing heterogeneous nuclear RNA genes. The pattern of inhibition of growing nascent Balbiani ring chains indicated that the transcriptional process was interrupted at the level of chain elongation. The highly decondensed state of active Balbiani ring chromatin, however, remained unaffected after injection of topoisomerase I antibodies. These data are consistent with the interpretation that topoisomerase I is an essential component in the transcriptional process but not in the maintenance of the decondensed state of active chromatin.

This article has been cited by other articles:

• Mondal, N., Zhang, Y., Jonsson, Z., Dhar, S. K., Kannapiran, M., Parvin, J. D. (2003). Elongation by RNA polymerase II on chromatin templates requires topoisomerase activity. Nucleic Acids Res 31: 5016-5024 [Abstract] [Full Text]  
• Vanhoefer, U., Harstrick, A., Achterrath, W., Cao, S., Seeber, S., Rustum, Y. M. (2001). Irinotecan in the Treatment of Colorectal Cancer: Clinical Overview. JCO 19: 1501-1518 [Abstract] [Full Text]  
• Gobert, C., Skladanowski, A., Larsen, A. K. (1999). The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53. Proc. Natl. Acad. Sci. USA 96: 10355-10360 [Abstract] [Full Text]  
• Shykind, B M, Kim, J, Stewart, L, Champoux, J J, Sharp, P A (1997). Topoisomerase I enhances TFIID-TFIIA complex assembly during activation of transcription.. Genes Dev. 11: 397-407 [Abstract]  
• Bharti, A. K., Olson, M. O. J., Kufe, D. W., Rubin, E. H. (1996). Identification of a Nucleolin Binding Site in Human Topoisomerase I. J. Biol. Chem. 271: 1993-1997 [Abstract] [Full Text]  
• Edwards, T. K., Saleem, A., Shaman, J. A., Dennis, T., Gerigk, C., Oliveros, E., Gartenberg, M. R., Rubin, E. H. (2000). Role for Nucleolin/Nsr1 in the Cellular Localization of Topoisomerase I. J. Biol. Chem. 275: 36181-36188 [Abstract] [Full Text]